Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse  >  Allergan, Inc.    AGN

SummaryQuotesNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Allergan : Assigned Patent

08/26/2015 | 07:17am US/Eastern

By Targeted News Service

ALEXANDRIA, Va., Aug. 26 -- Allergan, Irvine, California, has been assigned a patent (9,114,111) developed by six co-inventors for "methods for sustained treatment of bladder pain and irritative voiding." The co-inventors are Julie Himes, Lexington, Massachusetts, Dennis Giesing, Lee's Summit, Missouri, Cheryl Larrivee-Elkins, Framingham, Massachusetts, Michael J. Cima, Winchester, Massachusetts, Purnanand Sarma, Concord, Massachusetts, and Paul Goldenheim, Cambridge, Massachusetts.

The patent application was filed on Jan. 10, 2012 (13/347,513). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=9,114,111.PN.&OS=PN/9,114,111&RS=PN/9,114,111

Written by Amal Ahmed; edited by Jaya Anand.

AM0826JA0826-1130513 93JAnand

(c) 2015 Targeted News Service, source News Service

React to this article
Latest news on ALLERGAN, INC.
08/26 ALLERGAN : Assigned Patent
08/24 ALLERGAN : Issues Voluntary Nationwide Recall In The U.S. Of Specific Lots Of RE..
08/24 ALLERGAN : Issues Voluntary Nationwide Recall in the U.S. of Specific Lots of RE..
08/19 ALLERGAN : Assigned Patent
08/18 Teva likely to oppose Mylan's bid to take over Perrigo
08/15 ALLERGAN : Completes Oculeve Acquisition
08/13 ALLERGAN : Finalizes Oculeve Acquisition
08/12 ALLERGAN : is earning bridge for Teva (Goldman Sachs)
08/12 IRONWOOD PHARMACEUTICALS : and Allergan Enter Agreement to Co-Promote VIBERZI fo..
08/10 ALLERGAN : New Podcast on Non-Surgical Facelift Featuring Chattanooga Aesthetics..
Advertisement
Income Statement Evolution
More Financials